DIO3, iodothyronine deiodinase 3, 1735

N. diseases: 80; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 GeneticVariation group BEFREE We discovered that Snail mediated the downregulation of the imprinted Dlk1-Dio3 locus, a complex genomic region containing protein-coding genes and non-coding RNAs that has been linked to tumor malignancy in lung cancer patients. 30190790 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 GeneticVariation group BEFREE The cluster of microRNAs (miRNAs) in the DLK1-DIO3 genomic imprinted region contains several miRNAs that have a significant regulatory role in tumor proliferation and invasion. 28043921 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 GeneticVariation group BEFREE Further, a large number of miRs observed in tumour network mapped to a specific chromosomal location in DLK1-DIO3 (Chr14q32); some of those miRs have also been associated with EMT and MET regulation. 29051564 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 Biomarker group BEFREE Type 3 deiodinase (DIO3, D3) is reactivated in human neoplasias. 26825960 2016
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 GeneticVariation group BEFREE Moreover, the high BCL-xL expression correlated with short treatment-free survival in 76 CLL patients. miR-377 is located at 14q32 in the DLK1-DIO3 region, which encodes the largest tumor suppressor miRNA cluster in humans. 26537004 2015
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 AlteredExpression group BEFREE The patient's tumor expressed increased levels of DIO3 and DLK1 mRNA and protein levels. 24646062 2014
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 GeneticVariation group BEFREE The analyses revealed the involvement of both coding and non coding RNAs (SNORDs located in DLK1-DIO3 region) and support a model of stepwise progression mainly driven by epigenetic changes involving tumour vascular supply and tumoral cellular component. 25115389 2014
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 Biomarker group BEFREE These results establish the DLKI-DIO3 miRNA cluster as a critical checkpoint regulating tumor growth and metastasis and implicate epigenetic modification of the cluster in driving tumor progression. 23105110 2012
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 Biomarker group BEFREE The thyroid-hormone-inactivating type 3 deiodinase (DIO3, D3) has been shown to be reactivated in human neoplasias. 22823995 2012